Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma

BACKGROUND: Tiotropium, a once-daily long-acting anticholinergic bronchodilator, when administered via Respimat® SoftMist™ inhaler (tiotropium Respimat®) significantly reduces the risk of severe exacerbations and improves lung function in patients with severe persistent asthma that is not fully cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeh, Kai-Michael, Moroni-Zentgraf, Petra, Ablinger, Othmar, Hollaenderova, Zuzana, Unseld, Anna, Engel, Michael, Korn, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066691/
https://www.ncbi.nlm.nih.gov/pubmed/24890738
http://dx.doi.org/10.1186/1465-9921-15-61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066691/
https://www.ncbi.nlm.nih.gov/pubmed/24890738
http://dx.doi.org/10.1186/1465-9921-15-61

Ejemplares similares